Urnov F D, Yee J, Sachs L, Collingwood T N, Bauer A, Beug H, Shi Y B, Wolffe A P
Sangamo Biosciences, Point Richmond Technology Centre, 501 Canal Boulevard, Suite A100, Richmond, CA 94804, USA.
EMBO J. 2000 Aug 1;19(15):4074-90. doi: 10.1093/emboj/19.15.4074.
Transcriptional repression by nuclear hormone receptors is thought to result from a unison of targeting chromatin modification and disabling the basal transcriptional machinery. We used Xenopus oocytes to compare silencing effected by the thyroid hormone receptor (TR) and its mutated version, the oncoprotein v-ErbA, on partly and fully chromatinized TR-responsive templates in vivo. Repression by v-ErbA was not as efficient as that mediated by TR, was significantly more sensitive to histone deacetylase (HDAC) inhibitor treatment and, unlike TR, v-ErbA required mature chromatin to effect repression. We find that both v-ErbA and TR can recruit the corepressor N-CoR, but, in contrast to existing models, show a concomitant enrichment for HDAC3 that occurs without an association with Sin3, HDAC1/RPD3, Mi-2 or HDAC5. We propose a requirement for chromatin infrastructure in N-CoR/HDAC3-effected repression and suggest that the inability of v-ErbA to silence on partly chromatinized templates may stem from its impaired capacity to interfere with basal transcriptional machinery function. In support of this notion, we find v-ErbA to be less competent than TR for binding to TFIIB in vitro and in vivo.
核激素受体介导的转录抑制作用被认为是靶向染色质修饰与抑制基础转录机制协同作用的结果。我们利用非洲爪蟾卵母细胞,在体内比较甲状腺激素受体(TR)及其突变体、癌蛋白v-ErbA对部分染色质化和完全染色质化的TR反应模板的沉默作用。v-ErbA介导的抑制作用不如TR有效,对组蛋白去乙酰化酶(HDAC)抑制剂处理更为敏感,并且与TR不同,v-ErbA需要成熟的染色质才能发挥抑制作用。我们发现v-ErbA和TR都能招募共抑制因子N-CoR,但与现有模型不同的是,它们会伴随HDAC3的富集,且这种富集不与Sin3、HDAC1/RPD3、Mi-2或HDAC5相关联。我们提出在N-CoR/HDAC3介导的抑制作用中需要染色质基础结构,并表明v-ErbA在部分染色质化模板上无法沉默可能源于其干扰基础转录机制功能的能力受损。支持这一观点的是,我们发现在体外和体内,v-ErbA与TFIIB结合的能力都不如TR。